Risk factors
Evolus (EOLS) risk factors
Item 1A of every Evolus, Inc. 10-K on file, and what changed from one year to the next.
- FY2025 10-K risk factors
59 risks, 10 new, 6 dropped, 10 reworded since the prior year. Evolus faces risks from ongoing operating losses, including a $661.0 million accumulated deficit and $51.6 million net loss in 2025. Trade policy threats include potential tariffs on products sourced from France and South Korea. Heavy reliance on key supply partners like Daewoong and Symatese underpins commercialization of Jeuveau and Evolysse.
Filed Mar 03, 2026 - FY2024 10-K risk factors
55 risks. The risk section is dominated by reliance on single-source suppliers Daewoong and Symatese for flagship products Jeuveau and Evolysse.
Filed Mar 04, 2025